| NOAC, n(%) | Warfarin, n(%) | Aspirin, n(%) | No medication, n(%) |
---|---|---|---|---|
CHA2DS2-VASc | ||||
 Male: 0~2; female: 0~1 | 18 (11.2) | 38 (23.6) | 37 (23.0) | 68 (42.2) |
 Male ≥3; female ≥2 | 48 (11.1) | 107 (24.8) | 132 (30.5) | 145 (33.6) |
HAS-BLED | ||||
  < 3 | 56 (10.5) | 131 (24.7) | 152 (28.6) | 192 (36.2) |
  ≥ 3 | 10 (16.1) | 14 (22.6) | 17 (27.4) | 21 (33.9) |